JPRN-UMIN000033862已完成未知
Feasibility study of Carbon-Ion Radiotherapy for Re-Irradiation of Locoregionally Recurrent Head and Neck Tumors - Carbon-Ion Radiotherapy for Re-Irradiation
Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology0 个研究点目标入组 48 人开始时间: 2018年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
The median follow-up period after re-irradiation was 27.1 months. Five patients (10.4%) developed Grade 3 acute toxicities and 18 (37.5%) developed Grade 3-5 late toxicities, including Grade 5 central nervous system necrosis in one patient. The 2-year local control, locoregional control, progression-free survival, and overall survival rates were 40.5, 33.5%, 29.4%, and 59.6%, respectively.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1years-old 至 999years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The presence of other primary cancers
研究者
相似试验
已完成
不适用
Carbon ion radiotherapy for stage I non-small cell lung cancerclinical stage I non-small cell lung cancerJPRN-UMIN000003797Gunma University Heavy Ion Medical Center37
已完成
2 期
Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal CancerRectal NeoplasmsNCT01060007Washington University School of Medicine80
已完成
不适用
Feasibility study of Carbon-Ion Radiotherapy for Re-Irradiation of Locoregionally Recurrent or Metastatic Lung Tumorsung cancer or metastatic lung tumorJPRN-UMIN000029313Hospital of the National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Sciences and Technology95
已完成
2 期
Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the OesophagusEsophageal CancerNCT01348217Centre Georges Francois Leclerc196
已完成
不适用
Phase II trial of carbon-ion radiotherapy with Gemcitabine for locally advanced pancreatic cancer (GUNMA1301)ocally advanced pancreatic cancerJPRN-UMIN000012296Gunma University Heavy Ion Medical Center21